Sublingual Misoprostol for the Prevention of Postpartum Haemorrhage – A Randomised Control Trial
European Journal of Molecular & Clinical Medicine,
2021, Volume 8, Issue 4, Pages 2218-2221
AbstractAim – The aim of the study was to study the effect of sublingual misoprostol for prevention of PPH.
Materials and Methods: This was a prospective, randomized, double blind, placebo controlled study. Inclusion criteria were women aged 20-40 years with 38-40 weeks of gestation who underwent elective caesarean section. Exclusion criteria were women have risk factors for post-partum haemorrhage, active thromboembolic disease and intrinsic risk for thrombosis. Participants were randomly assigned to misoprostol group or group A (n=50) and placebo group or group B(n=50). Group A received 400µg of sublingual misoprostol after delivery of the baby, group B received placebo tablet at the same time. Primary outcome measures were blood loss from delivery of the placenta to the end of the caesarean section to 2 hours postpartum, haemoglobin estimation was done in all patients pre operatively and 24 hours post operatively and the change in concentration was noted. Secondary outcome measures were need for additional uterotonics, use of additional surgical interventions to control post-partum haemorrhage.
Result: Blood loss from both placental delivery to the end of caesarean section and from end of caesarean section to 2 hours postpartum were significantly lower in the study group. (p<0.0001). Change in haemoglobin concentration in study group was also significantly less than in the control group. (p<0.0001). Total amount of Oxytocin required was significantly less in the study group (p=0.01). The number of women requiring other oxytocics (inj. Methyl ergometrine, inj. Carboprost) was significantly less in study group (p=0.0078). Conclusion – Sublingual misoprostol has been found to be effective in preventing PPH.
- Article View: 13
- PDF Download: 21